Advertisement
News
Advertisement

Stealthy Anexon raises $7M for heart disease tech

Wed, 10/20/2010 - 9:33am
Mass High Tech: The Journal of New England Technology

Stealthy cardiovascular biotech Anexon Inc. reports it has raised $7 million in new venture financing, naming the prestigious Mayo Clinic as an investor.

On Tuesday, the Cambridge company filed three separate documents with the U.S. Securities and Exchange Commission, reporting fundraises of $2 million, $3 million and $2 million again. The last $2 million is part of a planned $12 million round, the company reported. It was not clear whether the investments were concurrent, or had come separately in the three years since Anexon was founded with a reported $500,000 in seed money from Cambridge life sciences venture firm Healthcare Ventures.

SOURCE

Topics

Advertisement

Share this Story

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading